Healthpeak Properties, Inc.

Valuation Analysis

About the Company

Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare propert

Healthpeak Properties, Inc. Stock at a Glance

Healthpeak Properties, Inc. (DOC) is currently trading at $20.69 with a market capitalization of $14.3B. The trailing P/E ratio stands at 64.66x, with a forward P/E of 137.93x. The 52-week range spans from $15.70 to $20.82; the current price is 0.6% below the yearly high. Year-over-year revenue growth stands at +7.1%. The net profit margin stands at 7.73%.

💰 Dividend

Healthpeak Properties, Inc. pays an annual dividend of $1.22 per share, representing a yield of 5.9%. The payout ratio stands at 381.26%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

18 analysts rate Healthpeak Properties, Inc. (DOC) on consensus: Buy. The average price target is $21.06, implying +1.77% from the current price. Analyst price targets range from $17.00 to $29.00.

Healthpeak Properties, Inc.: The Investment Case in Detail

Healthpeak Properties, Inc. (DOC) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Earnings growth of 363.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

The Bear Case

A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

At a PEG of 4.32, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

What to Watch Next

• The share is trading at 97.5% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to market-like volatility, elevated short interest (5.24%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Healthpeak Properties, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.